The pooled SMD from the meta-analysis was 1.29 (95% CI: 0.61–1.97; P < 0.001), showing that the levels of IL-2 in external serum were significantly greater in patients with psoriasis compared to healthy controls (Fig S1 in S1 File). Here, IL2 is linked to psoriasis.